BIM
IMGN

BlackRock Investment Management’s Immunogen Inc IMGN Stock Holding History

BlackRock Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$654K Buy
320,809
+3,322
+1% +$6.67K ﹤0.01% 2938
2016
Q3 		$851K Sell
317,487
-747
-0.2% -$2.17K ﹤0.01% 2771
2016
Q2 		$980K Buy
318,234
+14,105
+5% +$88.4K ﹤0.01% 2654
2016
Q1 		$2.59M Buy
304,129
+16,638
+6% +$141K ﹤0.01% 1806
2015
Q4 		$3.9M Buy
287,491
+1,637
+0.6% +$20.1K 0.01% 1571
2015
Q3 		$2.74M Sell
285,854
-6,181
-2% -$90.4K ﹤0.01% 1824
2015
Q2 		$4.2M Buy
292,035
+55,898
+24% +$614K 0.01% 1636
2015
Q1 		$2.11M Buy
236,137
+1,851
+0.8% +$13.4K ﹤0.01% 1976
2014
Q4 		$1.43M Sell
234,286
-1,931
-0.8% -$17.7K ﹤0.01% 2297
2014
Q3 		$2.5M Buy
236,217
+1,420
+0.6% +$16.1K ﹤0.01% 1830
2014
Q2 		$2.78M Sell
234,797
-11,665
-5% -$146K ﹤0.01% 1819
2014
Q1 		$3.68M Buy
246,462
+1,263
+0.5% +$19.9K 0.01% 1604
2013
Q4 		$3.6M Sell
245,199
-5,724
-2% -$88K 0.01% 1586
2013
Q3 		$4.27M Buy
250,923
+10,545
+4% +$185K 0.01% 1398
2013
Q2 		$3.99M Buy
+240,378
New +$3.9M 0.01% 1372

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Investment Management's IMGN Position: Q4 2016 in Review

BlackRock Investment Management increased its Immunogen Inc (IMGN) stake by 1% in Q4 2016, buying an estimated $6.67K and bringing the position to 320,809 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

BlackRock Investment Management first reported a position in IMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.27M in Q3 2013. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Investment Management held 320,809 shares of Immunogen Inc worth $654K as of Q4 2016.
  • BlackRock Investment Management bought 3,322 Immunogen Inc shares in Q4 2016, an estimated $6.67K.
  • Immunogen Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2938 holding.
  • BlackRock Investment Management first reported a position in Immunogen Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Immunogen Inc position peaked at $4.27M in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.